RxDoctor Payments Data

Florence Abioye

Psychiatric/Mental Health · Flower Mound, TXNPI 1245730753

Payments from drug & device makers

$3,491in general payments, 2019–2025

Across 168 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$596
  • Otsuka America Pharmaceutical, Inc.$536
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$298
  • Alkermes, Inc.$262
  • Johnson & Johnson$213
  • Corium, LLC$210
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,44499%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,491 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine16$181,908
IngrezzaValbenazine Tosylate11$91,391
VraylarCariprazine Hcl14$27,228
Lurasidone Hcl18$9,948
Divalproex Sodium58$5,253
BelsomraSuvorexant11$4,908
Aripiprazole47$3,398
Bupropion XlBupropion Hcl78$2,120
Quetiapine Fumarate77$2,081
Duloxetine Hcl59$2,032
Quetiapine Fumarate ErQuetiapine Fumarate35$1,714
Hydroxyzine Hcl35$1,472
Olanzapine69$1,423
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$1,265
Clonazepam116$1,248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$124$181,90816 claims
Neurocrine Biosciences, Inc.Ingrezza$131$91,39111 claims
AbbVieVraylar$596$27,22814 claims
MerckBelsomra$27$4,90811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Flower Mound

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →